Page last updated: 2024-10-15
9-methylhypoxanthine
Description
9-methylhypoxanthine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
9-methylhypoxanthine : A methylhypoxanthine that is hypoxanthine with the methyl group at position 9. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 135408747 |
| CHEBI ID | 145736 |
| SCHEMBL ID | 1992701 |
| SCHEMBL ID | 9686102 |
| MeSH ID | M0501411 |
Synonyms (33)
| Synonym |
|---|
| nsc 4918 |
| nsc-4918 |
| 875-31-0 |
| nsc4918 |
| 9-methyl-1,9-dihydro-6h-purin-6-one |
| 9-methylpoxanthine |
| AKOS000320471 |
| F2124-0078 |
| 9-methyl-9h-purin-6-ol |
| CHEBI:145736 |
| 9-methylhypoxanthine |
| 9-methyl-3h-purin-6-one |
| AKOS006282735 |
| 9-methylpurin-6-ol |
| 113336-00-8 |
| SCHEMBL1992701 |
| SCHEMBL9686102 |
| TS-00059 |
| 9-methyl-6,9-dihydro-1h-purin-6-one |
| 9-methyl-3h-purin-6(9h)-one |
| 9-methyl-1,9-dihydro-6h-purin-6-one # |
| PESGUQRDJASXOR-UHFFFAOYSA-N |
| 6h-purin-6-one, 1,9-dihydro-9-methyl- |
| 9h-purin-6-ol, 9-methyl- (9ci) |
| DTXSID40236361 |
| 6h-purin-6-one, 1,9-dihydro-9-methyl- (9ci) |
| F12586 |
| 9-methyl-1h-purin-6-one |
| 9-methyl-3,9-dihydro-6h-purin-6-one |
| EN300-235734 |
| A923024 |
| 1,9-dihydro-9-methyl-6h-purin-6-one |
| mfcd00955774 |
Drug Classes (1)
| Class | Description |
|---|
| methylhypoxanthine | An oxopurine that is hypoxanthine with at least one methyl group substituted on to the ring. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |